Valneva Stock Price Drops 40% as UK cancels vaccine deal
Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
Read moreValneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
Read moreThe NHS-Galleri Trial is being launched to evaluate whether a blood test may help identify cancer earlier when combined with
Read moreAmgen’s first-in-class KRAS G12C inhibitor LumykrasTM (sotorasib) has been granted Conditional Marketing Authorisation by the Medicines and Healthcare products Regulatory
Read moreBoehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read moreSanofi announced that it will purchase U.S. biotech Kadmon to enhance its transplant business for approximately $1.9 billion. Sanofi and
Read moreAstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the
Read moreVertex Pharmaceuticals Incorporated and Arbor Biotechnologies unveiled they have entered into a new cooperation to accelerate the development of novel
Read moreThe UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Conditional Marketing Authorization (CMA) for Regeneron’s antibody cocktail to treat
Read moreThe U.S. Food and Drug Administration announced on Monday it has approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine which will
Read moreThe global leader in serving science, Thermo Fisher Scientific has announced that the U.S. Food and Drug Administration (FDA) has
Read more